Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease

NCT05572996 ·Status: AVAILABLE

Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

NCT01728220 ·Status: COMPLETED ·Phase: PHASE2

Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

NCT04358588 ·Status: NO_LONGER_AVAILABLE

Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH

NCT02652429 ·Status: UNKNOWN ·Phase: PHASE3

Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide

NCT02170519 ·Status: TERMINATED ·Phase: PHASE4

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

NCT01457781 ·Status: COMPLETED ·Phase: PHASE2

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

NCT00109681 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

NCT02725372 ·Status: TERMINATED ·Phase: PHASE3

Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric

NCT03602781 ·Status: WITHDRAWN ·Phase: PHASE3

Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes

NCT03081052 ·Status: COMPLETED ·Phase: PHASE4

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

NCT05867914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide

NCT04231084 ·Status: COMPLETED ·Phase: PHASE4

iNOPulse for COVID-19

NCT04398290 ·Status: WITHDRAWN ·Phase: PHASE2

Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension

NCT00709098 ·Status: COMPLETED ·Phase: PHASE3

Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension

NCT00352430 ·Status: COMPLETED ·Phase: PHASE1

Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

NCT03015402 ·Status: COMPLETED ·Phase: PHASE2

Inhaled Nitrite in Subjects With Pulmonary Hypertension

NCT01431313 ·Status: COMPLETED ·Phase: PHASE2

An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT06939647 ·Status: AVAILABLE

Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension

NCT00403650 ·Status: COMPLETED ·Phase: PHASE4

Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease

NCT01319045 ·Status: TERMINATED ·Phase: NA

Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis

NCT00439543 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Natrecor for Pulmonary Hypertension in Lung Transplants

NCT00205426 ·Status: COMPLETED ·Phase: PHASE4

Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

NCT05844462 ·Status: RECRUITING ·Phase: PHASE3

Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

NCT01894035 ·Status: COMPLETED

iNO300 Therapy in Critically Ill Patients With Pneumonia

NCT06950294 ·Status: RECRUITING ·Phase: EARLY_PHASE1